Observational studyJournal of neurology2024

Pediatric-onset Multiple Sclerosis treatment: a multicentre observational study comparing natalizumab with fingolimod.

Antonio Carotenuto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.